The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.2 - Manufacture of pharmaceutical preparations
400 jobs Number of planned job losses
Announcement Date
15 May 2012
Employment effect (start)
Foreseen end date
Description
Anglo-Swedish pharmaceutical manufacturer Astra Zeneca continues their workforce reductions in Sweden and will cut 400 jobs. The cutbacks will mostly affect Södertälje in Sweden. This job reduction was expected.
In February 2012 the company announced they would cut 1,100-1,200 positions at their plant in Södertälje, (see fact sheet 19819). The additional 400 positions will be for economists, lawyers, human resources managers, IT technicians and lab technicians.
The negotiations are not yet completed and the timeline for the restructuring is yet to be announced.
Sources
15 May 2012: Sydsvenskan
Citation
Eurofound (2012), Astra Zeneca, Internal restructuring in Sweden, factsheet number 73562, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/73562.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
